Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Altering cannabinoid signaling during development disrupts neuronal activity

Open access
Bernard, C., Milh, M., Morozov, Y. M., Ben-Ari, Y., Freund, T. F., Gozlan, H. · 2005 · Proceedings of the National Academy of Sciences

Abstract

In adult cortical tissue, recruitment of GABAergic inhibition prevents the progression of synchronous population discharges to epileptic activity. However, at early developmental stages, GABA is excitatory and thus unable to fulfill this role. Here, we report that retrograde signaling involving endocannabinoids is responsible for the homeostatic control of synaptic transmission and the resulting network patterns in the immature hippocampus. Blockade of cannabinoid type 1 (CB1) receptor led to epileptic discharges, whereas overactivation of CB1 reduced network activity in vivo . Endocannabinoid signaling thus is able to keep population discharge patterns within a narrow physiological time window, balancing between epilepsy on one side and sparse activity on the other, which may result in impaired developmental plasticity. Disturbing this delicate balance during pregnancy in either direction, e.g., with marijuana as a CB1 agonist or with an antagonist marketed as an antiobesity drug, can have profound consequences for brain maturation even in human embryos.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.0409641102

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 35 references

Research works printed but not linked: 1

  1. 10.1111/j.1471-0528.2002.01020.x · doi:10.1111/j.1471-0528.2002.01020.x · Paper page

Cited by

See all 157

Metadata

Authors
Bernard, C., Milh, M., Morozov, Y. M., Ben-Ari, Y., Freund, T. F., & Gozlan, H.
Affiliations
  • Inserm (FR)
  • Institut de Neurobiologie de la Méditerranée–Institut National de la Santé et de la Recherche Médicale U29, 163 Route de Luminy BP13, 13273 Marseille Cédex 09, France; and Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest 8., Szigony u. 43, H-1083, Hungary
Venue
Proceedings of the National Academy of Sciences
Published
2005-06-17
Volume
102
Issue
26
Pages
9388-9393
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2078267242
Cited by
144
References
35
Citations by year
2026: 3 · 2025: 6 · 2024: 2 · 2023: 3 · 2022: 2 · 2021: 4 · 2020: 4 · 2019: 3 · 2018: 7 · 2017: 6 · 2016: 7 · 2015: 6 · 2014: 6 · 2013: 5 · 2012: 11
FWCI
9.36
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
Keywords
endocannabinoids, cannabinoid type 1 receptor, CB1 receptor, GABAergic inhibition, epileptic discharges, synaptic homeostasis, immature hippocampus, neuronal network activity, developmental plasticity, prenatal cannabinoid exposure, cannabis, anti-obesity drugs, brain maturation
MeSH terms
Rimonabant, Animals, Brain, Cannabis, Electrodes, Electrophysiology, Female, Hippocampus, Immunohistochemistry, Male, Microscopy, Electron, Neurons, Piperidines, Pyrazoles, Receptors, GABA-A, Time Factors, Signal Transduction, Rats, Wistar, Substance-Related Disorders, Receptor, Cannabinoid, CB1, Rats, Cannabinoid Receptor Modulators

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.